| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $8.4B | $7.3B |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| R&D Expense | $0.1B | $0.0B |
| SG&A Expense | $0.3B | $0.3B |
| Operating Income | — | — |
| Net Income | $0.3B | $0.1B |
| EPS (Basic) | $1.95 | $0.38 |
| EPS (Diluted) | $1.92 | $0.38 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $5.4B | $4.7B |
| Current Assets | $2.3B | $1.8B |
| Cash & Equivalents | $0.1B | $0.1B |
| Total Liabilities | $4.4B | $4.0B |
| Current Liabilities | $1.8B | $1.4B |
| Stockholders' Equity | $1.0B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.5B | $0.3B |
| Investing Cash Flow | $-0.3B | $-0.3B |
| Capital Expenditures | $0.3B | $0.4B |
| Financing Cash Flow | $-0.2B | $-0.1B |